Prevalence of cardiovascular events in genetically confirmed versus unconfirmed familial hypercholesterolaemia

Introduction: Genetic testing for familial hypercholesterolaemia (FH) is not yet established for widespread use internationally to provide diagnostic confirmation, in part due to high cost and resource requirement. We need to establish whether genetic testing is clinically justified in terms of risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Tina Z, Breen, Jane, Neves, Emma, Grocott-Mason, Richard, Barbir, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Magdi Yacoub Heart Foundation 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768534/
https://www.ncbi.nlm.nih.gov/pubmed/33426041
http://dx.doi.org/10.21542/gcsp.2020.24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768534/
https://www.ncbi.nlm.nih.gov/pubmed/33426041
http://dx.doi.org/10.21542/gcsp.2020.24

Ejemplares similares